Cleared Traditional

QUANTA Flash CCP3, QUANTA Flash CCP3 Calibrators, and QUANTA Flash CCP3

K143754 · Inova Diagnostics, Inc. · Immunology
Sep 2015
Decision
264d
Days
Class 2
Risk

About This 510(k) Submission

K143754 is an FDA 510(k) clearance for the QUANTA Flash CCP3, QUANTA Flash CCP3 Calibrators, and QUANTA Flash CCP3, a Antibodies, Anti-cyclic Citrullinated Peptide (ccp) (Class II — Special Controls, product code NHX), submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on September 21, 2015, 264 days after receiving the submission on December 31, 2014. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5775.

Submission Details

510(k) Number K143754 FDA.gov
FDA Decision Cleared SESE
Date Received December 31, 2014
Decision Date September 21, 2015
Days to Decision 264 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code NHX — Antibodies, Anti-cyclic Citrullinated Peptide (ccp)
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5775
Definition The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis.

Similar Devices — NHX Antibodies, Anti-cyclic Citrullinated Peptide (ccp)

All 20
ADVIA Centaur Anti-CCP IgG (aCCP) assay including Reagents and Calibrators, Quality Controls and Master Curve Materials.
K153551 · Axis-Shield Diagnostics Limited · Aug 2016
IMMULITE 2000 ANTI-CCP IGG ASSAY
K121576 · Siemens Healthcare Diagnostics, Inc. · Apr 2013
MULTI-ANALYTE DETECTION SYSTEMS
K112810 · Bio-Rad Laboratories · Oct 2011
AXIS-SHIELD ANTI-CCP
K110296 · Axis-Shield Diagnostics, Ltd. · Aug 2011
CCPOINT
K093908 · Euro-Diagnostica AB · Dec 2010
BIOPLEX 2200 ANTI-CCP KIT ON THE BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM
K093954 · Bio-Rad Laboratories · Aug 2010